Medication info

Polajet Tablet (Pola-Prezingk)

Prescription medicationTabletOralExpired
Ingredient · strength
Polaprezinc›75mg / 1 tablet
Manufacturer / importer
Kuju Pharmaceutical Co., Ltd.
Appearance
White round tablet
Packaging
30 tablets/bottle, 300 tablets/bottle
Approval status
Expired

MFDS item code 202003530 · Approved 2020.05.15

This product's status changed to Expired on 2025.05.15. It may no longer be sold, so consult a doctor or pharmacist before taking it.

Summary

Main use
Treatment of gastric ulcers and improvement of gastric mucosal lesions during acute exacerbations of acute or chronic gastritis
Who takes it
Adults
Adult dose
Adults usually take 75mg (1 tablet) orally twice daily, after breakfast and before bedtime.

Ingredients

Manufacturer
Kuju Pharmaceutical Co., Ltd.

Efficacy & effects

Treatment of gastric ulcers and improvement of gastric mucosal lesions during acute exacerbations of acute or chronic gastritis

  • Gastric ulcer
  • gastric mucosal lesions
  • erosions
  • bleeding
  • redness
  • swelling
  • acute gastritis
  • acute exacerbations of chronic gastritis
View approved original text

This medication is used for the treatment of gastric ulcers. It also helps improve gastric mucosal lesions appearing during acute exacerbations of acute gastritis and chronic gastritis, such as erosions, bleeding, redness, and swelling. Therefore, it is used to effectively alleviate the damage and inflammation of the gastric mucosa, improving the symptoms of patients.

How to take

Adult dose

Adults usually take 75mg (1 tablet) orally twice daily, after breakfast and before bedtime.

Precautions

This medication can affect liver function, so if any signs of liver dysfunction or jaundice appear, discontinue use immediately and receive appropriate treatment. The zinc component contained in this medication may interfere with copper absorption, which can lead to symptoms of copper deficiency. Care should be taken as anemia and other symptoms can occur, particularly in patients with poor nutritional status. If hypersensitivity symptoms such as rash, itching, or hives occur during use, discontinue the medication immediately. Gastrointestinal symptoms such as nausea, constipation, vomiting, heartburn, and diarrhea have been reported, and appropriate measures should be taken if these symptoms occur. Various adverse reactions such as nausea, dyspepsia, liver function abnormalities, and blood abnormalities have been reported in clinical trials and post-marketing studies, so the patient's condition should be closely monitored during use. This medication may reduce the effectiveness of penicillamine or levothyroxine sodium, so if it is necessary to take them together, care should be taken to space out the dosages. Pregnant women or women who may become pregnant should use this medication cautiously only when necessary, as its safety has not been established. Nursing mothers are advised to avoid breastfeeding since the medication can be transmitted through breast milk. The safety in pediatric patients has not been established, so it is preferable not to use it in children. Elderly patients may have decreased gastrointestinal function, so the dosage should be reduced, and the patient's condition should be closely monitored during use. This medication should be kept out of the reach of children, and it is important not to transfer it to another container to maintain quality.

Side effects

  • liver dysfunction
  • jaundice
  • copper deficiency
  • pancytopenia
  • anemia
  • hypersensitivity
  • rash
  • itching
  • hives
  • eosinophilia
Show 47 more
  • leukopenia
  • thrombocytopenia
  • elevated AST
  • elevated ALT
  • elevated ALP
  • elevated LDH
  • elevated γ-GTP
  • constipation
  • nausea
  • abdominal distension
  • vomiting
  • heartburn
  • diarrhea
  • nausea
  • indigestion
  • cerebral infarction
  • seizures
  • subdural hemorrhage
  • esophageal carcinoma
  • amyloidosis
  • ureteral stones
  • gum bleeding
  • spinal stenosis
  • exacerbation of pancreatitis
  • cough
  • chest pain
  • myalgia
  • loss of appetite
  • dizziness
  • sputum disease
  • cold
  • headache
  • neck tension
  • cataract
  • abdominal discomfort
  • edema
  • specific illnesses
  • upper respiratory tract infection
  • facial swelling
  • sore throat
  • gastroesophageal reflux
  • generalized edema
  • rhinitis
  • runny nose
  • lung disease
  • erythematous rash
  • abdominal pain

Not everyone experiences these, and they can vary from person to person.

Storage

This medication should be stored in a tightly closed container to prevent exposure to air or moisture. It is recommended to maintain the storage temperature between 1 degree and 30 degrees Celsius.

Appearance and packaging

Appearance

White round tablet

Package unit

30 tablets/bottle, 300 tablets/bottle

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.